The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Research Report 2024
Synopsis
The global Biosynthetic Human Milk Oligosaccharides (HMOs) market was valued at US$ 459.4 million in 2023 and is anticipated to reach US$ 2153.1 million by 2030, witnessing a CAGR of 24.6% during the forecast period 2024-2030.
The top four global companies of Biosynthetic Human Milk Oligosaccharides (HMOs) are Abbott, Dupont (Inbiose), DSM (Glycom), and Chr. Hansen (Jennewein) dominate the market. Abbott is the largest player, followed by DSM (Glycom). Global Biosynthetic Human Milk Oligosaccharides are mainly produced in North America and Europe, with North America holding about 60% of the market share. In terms of its type, 2'-Fucose lactose and 3-Fucose lactose hold about 90% of the market share. In terms of application, infant formula application occupies an absolutely important market position.
This report aims to provide a comprehensive presentation of the global market for Biosynthetic Human Milk Oligosaccharides (HMOs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosynthetic Human Milk Oligosaccharides (HMOs).
Report Scope
The Biosynthetic Human Milk Oligosaccharides (HMOs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosynthetic Human Milk Oligosaccharides (HMOs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosynthetic Human Milk Oligosaccharides (HMOs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Dupont (Inbiose)
DSM (Glycom)
Chr. Hansen (Jennewein)
BASF
FrieslandCampina
Segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.
Segment by Application
Infant Formula
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthetic Human Milk Oligosaccharides (HMOs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Biosynthetic Human Milk Oligosaccharides (HMOs) market was valued at US$ 459.4 million in 2023 and is anticipated to reach US$ 2153.1 million by 2030, witnessing a CAGR of 24.6% during the forecast period 2024-2030.
The top four global companies of Biosynthetic Human Milk Oligosaccharides (HMOs) are Abbott, Dupont (Inbiose), DSM (Glycom), and Chr. Hansen (Jennewein) dominate the market. Abbott is the largest player, followed by DSM (Glycom). Global Biosynthetic Human Milk Oligosaccharides are mainly produced in North America and Europe, with North America holding about 60% of the market share. In terms of its type, 2'-Fucose lactose and 3-Fucose lactose hold about 90% of the market share. In terms of application, infant formula application occupies an absolutely important market position.
This report aims to provide a comprehensive presentation of the global market for Biosynthetic Human Milk Oligosaccharides (HMOs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosynthetic Human Milk Oligosaccharides (HMOs).
Report Scope
The Biosynthetic Human Milk Oligosaccharides (HMOs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosynthetic Human Milk Oligosaccharides (HMOs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosynthetic Human Milk Oligosaccharides (HMOs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Dupont (Inbiose)
DSM (Glycom)
Chr. Hansen (Jennewein)
BASF
FrieslandCampina
Segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.
Segment by Application
Infant Formula
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthetic Human Milk Oligosaccharides (HMOs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 2'-FL & 3-FL
1.2.3 LNT & LNnT, etc.
1.3 Market by Application
1.3.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infant Formula
1.3.3 Other Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Perspective (2019-2030)
2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Growth Trends by Region
2.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Region (2019-2024)
2.2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2025-2030)
2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Dynamics
2.3.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Industry Trends
2.3.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers
2.3.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges
2.3.4 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue
3.1.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue (2019-2024)
3.1.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Players (2019-2024)
3.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue
3.4 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio
3.4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2023
3.5 Biosynthetic Human Milk Oligosaccharides (HMOs) Key Players Head office and Area Served
3.6 Key Players Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service
3.7 Date of Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Type
4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Type (2019-2024)
4.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2025-2030)
5 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Application
5.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Application (2019-2024)
5.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2019-2030)
6.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2019-2024)
6.4 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2019-2030)
7.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2019-2024)
7.4 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2019-2030)
8.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2019-2024)
8.4 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2019-2030)
9.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2019-2024)
9.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2019-2030)
10.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2019-2024)
10.4 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.1.4 Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Dupont (Inbiose)
11.2.1 Dupont (Inbiose) Company Detail
11.2.2 Dupont (Inbiose) Business Overview
11.2.3 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.2.4 Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.2.5 Dupont (Inbiose) Recent Development
11.3 DSM (Glycom)
11.3.1 DSM (Glycom) Company Detail
11.3.2 DSM (Glycom) Business Overview
11.3.3 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.3.4 DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.3.5 DSM (Glycom) Recent Development
11.4 Chr. Hansen (Jennewein)
11.4.1 Chr. Hansen (Jennewein) Company Detail
11.4.2 Chr. Hansen (Jennewein) Business Overview
11.4.3 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.4.4 Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.4.5 Chr. Hansen (Jennewein) Recent Development
11.5 BASF
11.5.1 BASF Company Detail
11.5.2 BASF Business Overview
11.5.3 BASF Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.5.4 BASF Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.5.5 BASF Recent Development
11.6 FrieslandCampina
11.6.1 FrieslandCampina Company Detail
11.6.2 FrieslandCampina Business Overview
11.6.3 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.6.4 FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2019-2024)
11.6.5 FrieslandCampina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
